Table 1.
Patient number | Type of sample | Organisms isolated | Antibiotics received on admission | Susceptibility of isolates to empirical antibiotics received |
---|---|---|---|---|
1 | Blood culture | Escherichia coli | Teicoplanin and clarithromycina | No |
2 | Blood culture | Escherichia coli | Ceftriaxone and clarithromycin | No |
3 | Blood culture | Klebsiella pneumoniae | Not received (patient on palliative pathway) | Not applicable |
4 | Blood cultureb | Klebsiella variicola | Ciprofloxacin | Yes |
5 | Blood culture | Proteus mirabilis | Ceftriaxone and clarithromycin | Yes |
6 | Blood culture | Proteus mirabilis | Ceftriaxone and clarithromycin | Yes |
7 | Blood culture | Proteus mirabilis | Ceftriaxone and amikacin | Yes |
8 | Blood culture | Proteus mirabilis | Ciprofloxacin and amikacin | Yes |
9 | Blood culture | Pseudomonas aeruginosa | Co-amoxiclav and amikacin | Yes |
10 | Blood culture | MRSA | Ceftriaxone and clarithromycin | Yes |
11 | Blood culture | MSSA | Ceftriaxone and clarithromycin | Yes |
12 | Blood culture (central line) | Staphylococcus epidermidis | Ceftriaxone and clarithromycin | No |
13 | Sputum | Escherichia coli (ESBL), Candida albicans | Ceftriaxone and clarithromycin | No |
14 | Sputum | Group A Streptococcus | Teicoplanin and clarithromycina | Yes |
15 | Sputum | Haemophilus influenzae | Cefuroxime | Yes |
16 | Sputum | Pseudomonas aeruginosa, Candida spp | Cefuroxime and clarithromycin | No |
17 | Sputum | MSSA | Ceftriaxone and clarithromycin | Yes |
18 | Sputum | MSSA | Ceftriaxone and clarithromycin | Yes |
19 | Sputum | MSSA | Ceftriaxone and clarithromycin | Yes |
20 | Sputum | MSSA | Ceftriaxone and clarithromycin | Yes |
21 | Urine (catheter) | Coliform, Candida species | Cefuroxime and clarithromycin | Yes |
22 | Urine | Escherichia coli | Co-amoxiclav and clarithromycin | Yes |
23 | Urine (catheter) | Escherichia coli | Co-amoxiclav and clarithromycin | Yes |
24 | Urine (catheter) | Escherichia coli | Ceftriaxone | Yes |
25 | Urine | Escherichia coli | Piperacillin/tazobactam and gentamicin | Yes |
26 | Urine | Escherichia coli | Piperacillin/tazobactam | Yes |
27 | Urine (catheter) | Escherichia coli (ESBL), Enterococcus faecalis | Ceftriaxone and amikacin | Yes |
28 | Urine | Enterococcus faecalis | Ceftriaxone and amikacin | Yes |
29 | Urine | Klebsiella pneumoniae | Piperacillin/tazobactam and teicoplanin (neutropenic sepsis) | No |
4 | Urine (nephrostomy)b | Klebsiella variicola | Ciprofloxacin | Yes |
30 | Urinary pneumococcal antigen test | Streptococcus pneumoniae | Piperacillin/tazobactam and clarithromycin | Yes |
31 | Urinary pneumococcal antigen test | Streptococcus pneumoniae | Teicoplanin and clarithromycina | Yes |
32 | Urinary pneumococcal antigen test | Streptococcus pneumoniae | Ceftriaxone and clarithromycin | Yes |
33 | Eye swab | MSSA | Ceftriaxone and clarithromycin | Yes |
34 | Foot ulcer swab | Serratia species | Benzylpenicillin, flucloxacillin and gentamicin | Yes |
35 | Foot ulcer swab | MSSA | Ceftriaxone, clarithromycin and doxycycline | Yes |
36 | Psoas abscess drainage |
Specimen 1: Escherichia coli (ESBL), Klebsiella oxytoca, Streptococcus anginosus, Candida species, Bacteroides ovatus Specimen 2: Granulicatella adiacens, Escherichia coli (ESBL), Escherichia coli, anaerobe |
Piperacillin/tazobactam and clarithromycin | Yes |
37 | Surgical wound swab |
Specimen 1: Group A streptococcus Specimen 2: Staphylococcus aureus |
Co-amoxiclav | Yes |
History of penicillin allergy.
Specimens from the same patients.